PER-049-02已完成未知
DOUBLE BLIND STUDY PARALLEL RANDOMIZED AND ACTIVE COMPARATOR WHOSE PURPOSE IS TO EVALUATE THE SAFETY AND EFFICACY OF CELECOXIB IN SUSPENSION COMPARED WITH NAPROXEN IN SUSPENSION IN PATIENTS WITH YOUNG RHEUMATOID ARTHRITIS.
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,0 个研究点目标入组 0 人开始时间: 2002年7月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. The patient has a diagnosis of JRA of a polyarticular or oligoarticular course determined according to the CAR criteria. Patients with systemic onset JRA who have a polyarticular or oligoarticular course are eligible. Patients with Active systemic characteristics will not be included.
- •2. The patient is at least two years old and has not yet reached his 17th birthday.
- •3. The patient must weigh at least 15 kg.
- •4. The patient must have> 1 swollen joint and> 1 joint with limitation of the movement. Joints with limited range of movements can be the same as the swollen joints.
- •5. Must have rm CESN score of> 0.2.
- •6. Must have a global evaluation by the physician and the father in the selection of> 20 mm on a 100 mm EVA scale.
排除标准
- •1. The patient is in the active phase of systemic JRA.
- •2. The patient has received or has been exposed to investigational drugs within the specified times before receiving the first dose of the medication.
研究者
相似试验
已完成
不适用
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia-J189 Pneumonia, unspecifiedPneumonia, unspecifiedJ189PER-056-06ADVANCE LIFE SCIENCE, INC.,
已完成
不适用
DOUBLE BLIND, RANDOM, TWO ARM, PARALLEL STUDY WITH LOSARTAN OR ATENOLOL FOR THE EVALUATION OF THE HEALTH OF PATIENTS WITH MILD TO MODERATE HYPERTENSIO-I10 Essential (primary) hypertension-F529 Unspecified sexual dysfunction, not caused by organic disorder or diseaseUnspecified sexual dysfunction, not caused by organic disorder or diseaseEssential (primary) hypertensionF529I10PER-032-01MERCK SHARP & DOHME PERU S.R.L.,
进行中（未招募）
不适用
PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND STUDY, PARALLEL-GROUP, MULTI-CENTER TRIAL ASSESSING THE EFFECTS OF ESCALATING DOSES OF BF2.649 AND BF2.649 ADD ON MODAFINIL ON CATAPLEXY IN PATIENTS WITH NARCOLEPSY(HARMONY II”) - Harmony IIEUCTR2008-007845-29-HUBioprojet40
未知
不适用
A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, INDUCED UNDER INTERNAL BLIND CONDITIONS, TO DETERMINE THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF THE APREPITANT REGIME COMPARED TO AN ONDASETRON REGIME FOR THE PREVENTION OF NAUSEA AND VOMITES INDUCED BY CHEMOTHERAPY, ASSOCIATED WITH HIGH DOSE OF CISPLATINO IN CYCLE 1.PER-057-03MERCK & CO.INC.,
未知
不适用
A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF 52 WEEKS OF ONCE DAILY TREATMENT OF ORALLY INHALED TIOTROPIUM + OLODATEROL FIXED DOSE COMBINATION (2.5 µG / 5 µG; 5 µG / 5 µG) (DELIVERED BY THE RESPIMAT) COMPARED…PER-089-11Boehringer Ingelheim,